Skp2 Expression Is Inhibited by Arsenic Trioxide through the Upregulation of miRNA-330-5p in Pancreatic Cancer Cells
Open Access
- 1 March 2019
- journal article
- research article
- Published by Elsevier in Molecular Therapy-Oncolytics
- Vol. 12, 214-223
Abstract
No abstract availableKeywords
Funding Information
- Baotou Science and Technology Bureau (16S-03)
This publication has 39 references indexed in Scilit:
- Roles of F-box proteins in cancerNature Reviews Cancer, 2014
- Arsenic trioxide inhibits viability of pancreatic cancer stem cells in culture and in a xenograft model via binding to SHH-GliOncoTargets and Therapy, 2013
- Pharmacological Inactivation of Skp2 SCF Ubiquitin Ligase Restricts Cancer Stem Cell Traits and Cancer ProgressionCell, 2013
- Inhibition of checkpoint kinase 2 (CHK2) enhances sensitivity of pancreatic adenocarcinoma cells to gemcitabineJournal of Cellular and Molecular Medicine, 2013
- The Skp2-SCF E3 Ligase Regulates Akt Ubiquitination, Glycolysis, Herceptin Sensitivity, and TumorigenesisCell, 2012
- The microcosmos of cancerNature, 2012
- Skp2: A novel potential therapeutic target for prostate cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2012
- Ubiquitin‐mediated control of oncogene and tumor suppressor gene productsCancer Science, 2009
- High-level Skp2 Expression in Pancreatic Ductal AdenocarcinomaPancreas, 2006
- Degradation of p57
Kip2
mediated by SCF Skp2 -dependent ubiquitylationProceedings of the National Academy of Sciences, 2003